Profile
Thomas E.
Jenkins is the founder of Elysium Therapeutics, Inc., founded in 2013, where the title held is Chief Scientific Officer.
Former job includes Chief Scientific Officer & Vice President-Research at Signature Therapeutics, Inc. Education history includes a doctorate from Stanford University and an undergraduate degree from the University of Akron.
Thomas Jenkins active positions
| Companies | Position | Start |
|---|---|---|
Elysium Therapeutics, Inc.
Elysium Therapeutics, Inc. BiotechnologyHealth Technology Engages in research and development in biotechnology | Founder | 01/01/2013 |
Former positions of Thomas Jenkins
| Companies | Position | End |
|---|---|---|
Signature Therapeutics, Inc.
Signature Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical products | Chief Tech/Sci/R&D Officer | - |
Training of Thomas Jenkins
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 4 |
|---|---|
Signature Therapeutics, Inc.
Signature Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical products | Health Technology |
Stanford University
Stanford University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Akron
University of Akron Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Elysium Therapeutics, Inc.
Elysium Therapeutics, Inc. BiotechnologyHealth Technology Engages in research and development in biotechnology | Health Technology |
- Stock Market
- Insiders
- Thomas Jenkins
















